With CBD projected to be a $450 Million industry in the coming year, FDA hosted a packed house of industry stakeholders last week in a day-long public meeting that was the kickoff of a discussion to determine whether there is a pathway for CBD in ingestible products such as foods and dietary supplements. See our summary of key themes here https://www.fooddruglaw.com/2019/06/01/fda-cbd-public-meeting-features-overwhelming-calls-for-robust-regulation-and-enforcement-relaxation-of-obstacles-to-research/ and check out this podcast episode to hear five key takeaways.